These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6147806)

  • 1. Treatment of ocular hypertension and glaucoma with dopamine antagonists.
    Chiou GC
    Ophthalmic Res; 1984; 16(3):129-34. PubMed ID: 6147806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of ocular blood flow with dopamine antagonists on ocular-hypertensive rabbit eyes.
    Chiou GC; Chen YJ
    Zhongguo Yao Li Xue Bao; 1992 Nov; 13(6):481-4. PubMed ID: 1302433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of D-timolol for the treatment of glaucoma and ocular hypertension.
    Chiou GC
    J Ocul Pharmacol; 1990; 6(1):67-74. PubMed ID: 2193994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antiglaucoma drugs on the blood flow in rabbit eyes.
    Chiou GC; Yan HY
    Ophthalmic Res; 1986; 18(5):265-9. PubMed ID: 3808590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular hypotensive actions of haloperidol, a dopaminergic antagonist.
    Chiou GC
    Arch Ophthalmol; 1984 Jan; 102(1):143-5. PubMed ID: 6703959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Histamine H₃ Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma.
    Lanzi C; Lucarini L; Durante M; Sgambellone S; Pini A; Catarinicchia S; Łażewska D; Kieć-Kononowicz K; Stark H; Masini E
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopamine antagonists injected through vortex veins on intraocular pressure.
    Chiou GC; Li BH; Chiou FY
    J Ocul Pharmacol; 1989; 5(4):281-91. PubMed ID: 2576433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of D-timolol on intraocular pressure (IOP), beta blocking activity, and the dynamic changes of drug concentrations in aqueous humor.
    Zhao F; Ji XC; Zheng YZ
    J Ocul Pharmacol; 1989; 5(4):271-9. PubMed ID: 2576432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An experimental study of the ocular hypotensive action of dopaminergic antagonists].
    Xia XP
    Zhonghua Yan Ke Za Zhi; 1989 May; 25(3):171-4. PubMed ID: 2582955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of D-timolol on intraocular pressure, heart rate, cardiac contractility, and tracheal muscle function.
    Chiou GC
    Curr Eye Res; 1982-1983; 2(8):507-10. PubMed ID: 7184703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a non-selective beta-blocker on adult rat anterograde axonal transport and retinal ganglion layer after increased intraocular pressure.
    Díaz F; Villena A; Moreno M; Vidal L; Parrado C; García-Campos J; de Vargas IP
    Histol Histopathol; 2005 Oct; 20(4):1077-84. PubMed ID: 16136490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
    Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
    PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beta-adrenergic blocking agents and the treatment of glaucoma.
    Zimmerman TJ; Boger WP
    Surv Ophthalmol; 1979; 23(6):347-62. PubMed ID: 37605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension.
    Craven ER; Walters TR; Williams R; Chou C; Cheetham JK; Schiffman R;
    J Ocul Pharmacol Ther; 2005 Aug; 21(4):337-48. PubMed ID: 16117698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-enantiomer of timolol: a potential selective ocular antihypertensive agent.
    Share NN; Lotti VJ; Gautheron P; Schmitt C; Gross DM; Hall RA; Stone CA
    Graefes Arch Clin Exp Ophthalmol; 1984; 221(5):234-8. PubMed ID: 6092239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
    Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA
    Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
    García Sanchez J
    Eur J Ophthalmol; 2000; 10(3):198-204. PubMed ID: 11071026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
    Weinreb RN; Scassellati Sforzolini B; Vittitow J; Liebmann J
    Ophthalmology; 2016 May; 123(5):965-73. PubMed ID: 26875002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.